Jazz Pharmaceuticals plc — Director's Dealing 2010

Mar 10, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-03-08

Reporting Person: Gamble Carol A (SVP, GC and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-03-09	Common Stock	S	1100	$11.40	Disposed	31859	Direct
2010-03-09	Common Stock	S	1700	$11.41	Disposed	30159	Direct
2010-03-09	Common Stock	S	3200	$11.42	Disposed	26959	Direct
2010-03-09	Common Stock	S	600	$11.43	Disposed	26359	Direct
2010-03-09	Common Stock	S	1500	$11.44	Disposed	24859	Direct
2010-03-09	Common Stock	S	3200	$11.45	Disposed	21659	Direct
2010-03-09	Common Stock	S	500	$11.46	Disposed	21159	Direct
2010-03-09	Common Stock	S	200	$11.47	Disposed	20959	Direct
2010-03-09	Common Stock	S	2467	$11.32	Disposed	18492	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-03-08	Option (right to buy)	$11.48	A	40000	Acquired	2020-03-07	Common Stock (40000)	Direct

Footnotes

F1: The options vest over four years measured from the vesting commencement date, March 8, 2010, with 1/4th vesting on the first anniversary of the vesting commencment date and the remainder vesting in 36 equal monthly installments thereafter.